_
Find a focused lung cancer treatment plan
Once you’ve had a comprehensive biomarker test, your doctor can see if any biomarkers are associated with your lung cancer. This allows your doctor to tailor their treatment decisions to your unique type of cancer. So you can have confidence moving forward with your treatment plan.
What your test results will tell you
The results of a comprehensive biomarker test will identify any biomarkers you have, some of which may point your doctor toward a treatment option. Knowing your complete biomarker status can help your doctor find the right treatment option for you.
Patients and lung cancer advocacy experts agree that comprehensive biomarker testing matters. See why.
There are many FDA-approved treatments for specific biomarkers in lung cancer, several other biomarker-driven treatments are in clinical trials, and it’s expected that many more will be developed as new breakthroughs in cancer treatment are made.
Some people with metastatic non-small cell lung cancer (mNSCLC) have a biomarker that can be targeted with a specific treatment.
If you test positive for one of these biomarkers, your doctor may start you on a treatment, or you may be eligible for a clinical trial.
Whether your test reveals multiple biomarkers, or none at all, having this information before starting treatment will help you and your doctor focus on a treatment path that makes sense for you.
Watch videos that may answer your questions about comprehensive biomarker testing.
